Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 4227 | 1824 | 30.2 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
| 822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
| 4227 | 1 | NISOLDIPINE//GALLOPAMIL//ELGODIPINE | 1824 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | NISOLDIPINE | authKW | 158079 | 2% | 24% | 39 |
| 2 | GALLOPAMIL | authKW | 141759 | 1% | 35% | 24 |
| 3 | ELGODIPINE | authKW | 135585 | 0% | 90% | 9 |
| 4 | NISOLDIPINE COAT CORE | authKW | 66957 | 0% | 100% | 4 |
| 5 | ANTIANGINA | authKW | 50217 | 0% | 100% | 3 |
| 6 | YM 16151 4 | authKW | 50217 | 0% | 100% | 3 |
| 7 | CARDIAC & CARDIOVASCULAR SYSTEM | WoSSC | 33675 | 53% | 0% | 968 |
| 8 | CONTROLLED DELIVERY DILTIAZEM | authKW | 33478 | 0% | 100% | 2 |
| 9 | DEFIANT STUDY | authKW | 33478 | 0% | 100% | 2 |
| 10 | SLOW RELEASE GALLOPAMIL | authKW | 33478 | 0% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 33675 | 53% | 0% | 968 |
| 2 | Pharmacology & Pharmacy | 3916 | 28% | 0% | 518 |
| 3 | Medicine, General & Internal | 2018 | 17% | 0% | 302 |
| 4 | Peripheral Vascular Diseases | 1398 | 9% | 0% | 160 |
| 5 | Medicine, Research & Experimental | 94 | 4% | 0% | 71 |
| 6 | Anesthesiology | 43 | 1% | 0% | 23 |
| 7 | Chemistry, Medicinal | 40 | 2% | 0% | 40 |
| 8 | Toxicology | 19 | 2% | 0% | 33 |
| 9 | Critical Care Medicine | 18 | 1% | 0% | 18 |
| 10 | Respiratory System | 17 | 1% | 0% | 26 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ADV MED TRAINING RETRAINING | 16739 | 0% | 100% | 1 |
| 2 | AZIENDA USL 5 PISA | 16739 | 0% | 100% | 1 |
| 3 | CANADIAN MULTI DILTIAZEM STUDY GRP | 16739 | 0% | 100% | 1 |
| 4 | CENT HOSP MED 1 INTENS CARE UNIT | 16739 | 0% | 100% | 1 |
| 5 | CIRCULATORY PATHOL | 16739 | 0% | 100% | 1 |
| 6 | CTMB | 16739 | 0% | 100% | 1 |
| 7 | HEART SECT | 16739 | 0% | 100% | 1 |
| 8 | IST MEDICINA INTERNA CARDIOL CARDIOCHIRURG | 16739 | 0% | 100% | 1 |
| 9 | MAX PLANCK CLIN PHYSIOL | 16739 | 0% | 100% | 1 |
| 10 | MAX PLANCK KLIN PHYSIOL FOR | 16739 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AMERICAN JOURNAL OF CARDIOLOGY | 23867 | 11% | 1% | 195 |
| 2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 15432 | 6% | 1% | 101 |
| 3 | ZEITSCHRIFT FUR KARDIOLOGIE | 11583 | 3% | 1% | 53 |
| 4 | AMERICAN HEART JOURNAL | 9380 | 5% | 1% | 90 |
| 5 | KARDIOLOGIYA | 8845 | 3% | 1% | 59 |
| 6 | EUROPEAN HEART JOURNAL | 7815 | 4% | 1% | 69 |
| 7 | CARDIOLOGY | 7762 | 2% | 1% | 39 |
| 8 | CARDIOVASCULAR DRUGS AND THERAPY | 6257 | 1% | 1% | 27 |
| 9 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5533 | 2% | 1% | 40 |
| 10 | CLINICAL CARDIOLOGY | 4257 | 2% | 1% | 34 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NISOLDIPINE | 158079 | 2% | 24% | 39 | Search NISOLDIPINE | Search NISOLDIPINE |
| 2 | GALLOPAMIL | 141759 | 1% | 35% | 24 | Search GALLOPAMIL | Search GALLOPAMIL |
| 3 | ELGODIPINE | 135585 | 0% | 90% | 9 | Search ELGODIPINE | Search ELGODIPINE |
| 4 | NISOLDIPINE COAT CORE | 66957 | 0% | 100% | 4 | Search NISOLDIPINE+COAT+CORE | Search NISOLDIPINE+COAT+CORE |
| 5 | ANTIANGINA | 50217 | 0% | 100% | 3 | Search ANTIANGINA | Search ANTIANGINA |
| 6 | YM 16151 4 | 50217 | 0% | 100% | 3 | Search YM+16151+4 | Search YM+16151+4 |
| 7 | CONTROLLED DELIVERY DILTIAZEM | 33478 | 0% | 100% | 2 | Search CONTROLLED+DELIVERY+DILTIAZEM | Search CONTROLLED+DELIVERY+DILTIAZEM |
| 8 | DEFIANT STUDY | 33478 | 0% | 100% | 2 | Search DEFIANT+STUDY | Search DEFIANT+STUDY |
| 9 | SLOW RELEASE GALLOPAMIL | 33478 | 0% | 100% | 2 | Search SLOW+RELEASE+GALLOPAMIL | Search SLOW+RELEASE+GALLOPAMIL |
| 10 | CAS 63675 72 9 | 30128 | 0% | 60% | 3 | Search CAS+63675+72+9 | Search CAS+63675+72+9 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HEIDENREICH, PA , MCDONALD, KM , HASTIE, T , FADEL, B , HAGAN, V , LEE, BK , HLATKY, MA , (1999) META-ANALYSIS OF TRIALS COMPARING BETA-BLOCKERS, CALCIUM ANTAGONISTS, AND NITRATES FOR STABLE ANGINA.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 281. ISSUE 20. P. 1927 -1936 | 53 | 55% | 155 |
| 2 | SOWARD, AL , VANHALEWEYK, GLJ , SERRUYS, PW , (1986) THE HEMODYNAMIC-EFFECTS OF NIFEDIPINE, VERAPAMIL AND DILTIAZEM IN PATIENTS WITH CORONARY-ARTERY DISEASE - A REVIEW.DRUGS. VOL. 32. ISSUE 1. P. 66-101 | 74 | 80% | 36 |
| 3 | PACKER, M , (1989) DRUG-THERAPY - COMBINED BETA-ADRENERGIC AND CALCIUM-ENTRY BLOCKADE IN ANGINA-PECTORIS.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 320. ISSUE 11. P. 709-718 | 64 | 63% | 93 |
| 4 | TEMKIN, LP , (1989) HIGH-DOSE MONOTHERAPY AND COMBINATION THERAPY WITH CALCIUM-CHANNEL BLOCKERS FOR ANGINA - A COMPREHENSIVE REVIEW OF THE LITERATURE.AMERICAN JOURNAL OF MEDICINE. VOL. 86. ISSUE 1A. P. 23-27 | 55 | 83% | 6 |
| 5 | CHAN, PK , HEO, JY , GARIBIAN, G , ASKENASE, A , SEGAL, BL , ISKANDRIAN, AS , (1988) THE ROLE OF NITRATES, BETA-BLOCKERS, AND CALCIUM-ANTAGONISTS IN STABLE ANGINA-PECTORIS.AMERICAN HEART JOURNAL. VOL. 116. ISSUE 3. P. 838-848 | 72 | 60% | 24 |
| 6 | EDOUTE, Y , NAGACHANDRAN, P , SVIRSKI, B , BEN-AMI, H , (2000) CARDIOVASCULAR ADVERSE DRUG REACTION ASSOCIATED WITH COMBINED BETA-ADRENERGIC AND CALCIUM ENTRY-BLOCKING AGENTS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 35. ISSUE 4. P. 556 -559 | 26 | 96% | 15 |
| 7 | PACKER, M , KESSLER, PD , LEE, WH , (1987) CALCIUM-CHANNEL BLOCKADE IN THE MANAGEMENT OF SEVERE CHRONIC CONGESTIVE-HEART-FAILURE - A BRIDGE TOO FAR.CIRCULATION. VOL. 75. ISSUE 6. P. 56-64 | 53 | 73% | 77 |
| 8 | STRAUSS, WE , PARISI, AF , (1988) COMBINED USE OF CALCIUM-CHANNEL AND BETA-ADRENERGIC BLOCKERS FOR THE TREATMENT OF CHRONIC STABLE ANGINA - RATIONALE, EFFICACY, AND ADVERSE-EFFECTS.ANNALS OF INTERNAL MEDICINE. VOL. 109. ISSUE 7. P. 570-581 | 47 | 82% | 33 |
| 9 | LANDAU, AJ , GENTILUCCI, M , CAVUSOGLU, E , FRISHMAN, WH , (1994) CALCIUM-ANTAGONISTS FOR THE TREATMENT OF CONGESTIVE-HEART-FAILURE.CORONARY ARTERY DISEASE. VOL. 5. ISSUE 1. P. 37-50 | 53 | 56% | 3 |
| 10 | SILBER, S , (1989) COMBINATION OF ANTIANGINOUS DRUGS.ZEITSCHRIFT FUR KARDIOLOGIE. VOL. 78. ISSUE . P. 160-174 | 66 | 55% | 1 |
Classes with closest relation at Level 1 |